Endomyocardial Fibrosis: Diagnosis and Management

References

• Mbanze J, Cumbane B, Jive R, Mocumbi A. Challenges in addressing the knowledge gap on endomyocardial fibrosis through community-based studies. Cardiovasc Diagn Ther. 2019. doi:10.21037/cdt.2019.08.07
   Web of Science ®Google Scholar
• Olsen EG, Spry CJ. The relation between esinophilia and endomyocardial disease. Prog Cardiovasc Dis. 1985;27(4):241–254. doi:10.1016/0033-0620(85)90008-8
   PubMed Web of Science ®Google Scholar
• Davies JNP, Ball JD. The pathology of endomyocardial fibrosis in Uganda. Br Heart J. 1955;17:337–359. doi:10.1136/hrt.17.3.337
   Google Scholar
• Loffler W. Endocarditis parietalis fibroplastica mit Bluteosinophilie: ein eingenartiges Krankheitsbild. Schweiz Med Wochenschr. 1936;17:817.
   Google Scholar
• Bedford DE, Konstam GLS. Heart failure of unknown etiology in Africans. Br Heart J. 1946;8:236.
   PubMedGoogle Scholar
• Davies JNP. Endomyocardial fibrosis in Africans. East Afr Med J. 1948;25:10–17.
   Google Scholar
• Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation. 2005;112(23):3577–3583. doi:10.1161/CIRCULATIONAHA.105.542894
   PubMed Web of Science ®Google Scholar
• Mocumbi AO, Ferreira MB, Sidi D, Yacoub MH. A population study of endomyocardial fibrosis in a rural area of Mozambique. N Engl J Med. 2008;359:43–49. doi:10.1056/NEJMoa0708629
   PubMed Web of Science ®Google Scholar
• Damasceno A, Mayosi BM, Sani M, et al. The Sub-Saharan Africa survey of heart failure (THESUS-HF). Arch Intern Med. 2012;172(18):1386–1394. doi:10.1001/archinternmed.2012.3310
   Google Scholar
• Beaton A, Mocumbi AO. Diagnosis and management of endomyocardial fibrosis. Cardiol Clinic. 2017;35:87–98. doi:10.1016/j.ccl.2016.08.005
   Web of Science ®Google Scholar
• Rashwan MA, Ayman M, Ashour S, Hassanin MM, Ziena AA. Endomyocardial fibrosis in Egypt. Br Heart J. 1995;73(3):284–289. doi:10.1136/hrt.73.3.284
   Google Scholar
• Mocumbi AOH, Falase AO. Recent advances in the epidemiology, diagnosis and treatment of endomyocardial fibrosis in Africa. Heart. 2013;99:1481–1487. doi:10.1136/heartjnl-2012-303193
   Web of Science ®Google Scholar
• Guimarães AC, Esteves JP, Filho AS, Macedo V. Clinical aspects of endomyocardial fibrosis in Bahia, Brazil. Am Heart J. 1971;81(1):7–19. doi:10.1016/0002-8703(71)90049-4
   Web of Science ®Google Scholar
• Vijayaraghavan G, Sivasankaran S. Tropical endomyocardial fibrosis in India: a vanishing disease. Indian J Med Res. 2012;136(5):729–738.
   Web of Science ®Google Scholar
• O’Brien W. Endocardial fibrosis in Sudan. Br Med J. 1954;2:899–903. doi:10.1136/bmj.2.4893.899
   Google Scholar
• El Hassan AM, Wasfi AI. Cardiovascular disease in Khartoum: post- mortem and clinical evidence. Trop Geogr Med. 1972;24:118–123.
   Google Scholar
• Yin R. Endomyocardial fibrosis in China. Chin Med Sci J. 2000;15(1):55–60.
   Google Scholar
• Niino T, Shiono M, Yamamoto T, et al. A case of left ventricular endomyocardial fibrosis. Ann Thorac Cardiovasc Surg. 2002;8:173–176.
   Google Scholar
• Connor DH, Somer K, Hutt MSR, Manion WC, D’Arbela PG. Endomyocardial fibrosis in Uganda. Am Heart J. 1967;74:687. doi:10.1016/0002-8703(67)90509-1
   Web of Science ®Google Scholar
• Freers J, Mayanja-Kizza H, Ziegler JL, Rutakingirwa M. Echocardiographic diagnosis of heart disease in Uganda. Trop Doct. 1996;26:125–128. doi:10.1177/004947559602600310
   PubMed Web of Science ®Google Scholar
• Falase AO. Endomyocardial fibrosis in Africa. Postgrad Med J. 1983;59:170–177. doi:10.1136/pgmj.59.689.170
   PubMed Web of Science ®Google Scholar
• Valiathan MS, Kartha CC. Endomyocardial fibrosis: a possible connection with the myocardial level of magnesium and Cerium. Int J Cardiol. 1989;28:1–5. doi:10.1016/0167-5273(90)90002-M
   Web of Science ®Google Scholar
• Brockington IF, Olsen EGJ, Goodwin JF. Endomyocardial fibrosis in Europeans resident in tropical Africa. Lancet. 1967;289:583–588. doi:10.1016/S0140-6736(67)90440-0
   Google Scholar
• Rutakingirwa M, Ziegler JL, Newton R, Freers J. Poverty, and esinophilia are risk factors for endomyocardial fibrosis (EMF) in Uganda. Trop Med Int Health. 1999;4:229–235. doi:10.1046/j.1365-3156.1999.43376.x
   PubMed Web of Science ®Google Scholar
• Freers J, Amandua J, Mugerwa R, Sezi C. Endomyocardial fibrosis and eosinophilia. Lancet. 1993;342:1233–1234. doi:10.1016/0140-6736(93)92211-B
   Google Scholar
• Andy JJ, Ogunowo PO, Akpan NA, Odigwe CO, Ekanem IA, Esin RA. Helminth associated hypereosinophilia and tropical endomyocardial fibrosis in Nigeria. Acta Trop. 1998;69:127–140. doi:10.1016/S0001-706X(97)00125-3
   Web of Science ®Google Scholar
• Tai PC, Ackerman SJ, Spry CJ, Dunnette S, Olsen EG, Gleich GJ. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial fibrosis. Lancet. 1987;1:643–647. doi:10.1016/S0140-6736(87)90412-0
   PubMed Web of Science ®Google Scholar
• Andrzej M, Rosiek M, Biegus J, Malolepszy J. Eotoxin and its role in the pathophysiology of eosinophilic inflammation. Alergia Astma Immunologia. 2003;8:19–24.
   Google Scholar
• Shaper AG. . Endomyocardial Fibrosi. In: Shaper AG, Hunt MSR, and Fejfar Z, editors. Cardiovascular Disease in the Tropics. London: British Medical Association; 1968.
   Google Scholar
• Shaper AG, Hutt MSR, Coles RM. Necropsy study of endomyocardial fibrosis and rheumatic heart disease in Uganda. Br Heart J. 1968;30:391. doi:10.1136/hrt.30.3.391
   Google Scholar
• Acquatella H, Nelson B, Schiller M. Value of two-dimensional echocardiography in endomyocardial disease with and without eosinophilia; a clinical and pathologic study. Circulation. 1983;67:1219–1226. doi:10.1161/01.CIR.67.6.1219
   PubMed Web of Science ®Google Scholar
• Syed IS, Martinez MW, Feng DL, Glockner JF. Cardiac magnetic resonance imaging of eosinophilic endomyocardial disease. Int J Cardiol. 2008;126:e50–e52. doi:10.1016/j.ijcard.2007.01.019
   Web of Science ®Google Scholar
• Alderman EL. Non-infective endocardial disease. Cardiovasc Dis. 1999. 1–7. doi:10.1016/s0021-9673(99)00837-7
   Google Scholar
• Khalil SI, Khalil SS, El Tigani S, Saad HA. Endomyocardial fibrosis in Sudan: clinical and echocardiographic features. Cardiovasc J Afr. 2017;28:222–228. doi:10.5830/CVJA-2016-079
   Web of Science ®Google Scholar
• Freers J, Mayanja-Kizza H, Rutakingirwa M, Gerwing E. Endomyocardial fibrosis: why is there striking ascites with little or no peripheral edema? Lancet. 1996;347:197. doi:10.1016/S0140-6736(96)90383-9
   Web of Science ®Google Scholar
• Makubi A, Hage C, Lwakatare J, et al. Prevalence and prognostic implications of anaemia and iron deficiency in Tanzanian patients with heart failure. Heart. 2015;101:592–599. doi:10.1136/heartjnl-2014-306890
   Web of Science ®Google Scholar
• Lang RM, Luigi P, Badano LP, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39. doi:10.1016/j.echo.2014.10.003
   PubMed Web of Science ®Google Scholar
• Connor DH, Somers K, Hutt MS, Manion WC, D’Arbela PG. Endomyocardial fibrosis in Uganda (Davies’ disease). II. An epidemiologic, clinical, and pathologic study. Am Heart J. 1968;75:107–124. doi:10.1016/0002-8703(68)90122-1
   PubMed Web of Science ®Google Scholar
• Mocumbi AO. Endomyocardial fibrosis: a form of endemic restrictive cardiomyopathy. Glob Cardiol Sci Pract. 2012;2012:11–23. doi:10.5339/gcsp.2012.11
   Google Scholar
• Fawzy ME, Ziady G, Halim NM, et al. Endomyocardial fibrosis: report of eight cases. J Am Coll Cardiol. 1985;5:983–988. doi:10.1016/S0735-1097(85)80444-7
   PubMed Web of Science ®Google Scholar
• Harbin AD, Gerson MC, O’Connell JB. Simulation of acute myopericarditis by constrictive pericardial disease with endomyocardial fibrosis due to methysergide therapy. J Am Coll Cardiol. 1984l;4:196–199. doi:10.1016/S0735-1097(84)80342-3
   Google Scholar
• Loseva MI, Purtova LA, Gavalova RF. Angiotensin converting enzyme inhibitor enalapril in the treatment of endomyocardial fibrosis in patients with lymphogranulomatosis subjected to radio- and chemotherapy. Kardiologiia. 2002;42:48–51.
   Web of Science ®Google Scholar
• Subair KM, Gupta PN, Suresh K, et al. The medical treatment of endomyocardial fibrosis in 2009. Heart Asia. 2011;120e123. doi:10.1136/ha.2010.003525
   Google Scholar
• Nabunnya YB, Kayima J, Longenecker CT, Josephson RA. The safety and efficacy of prednisolone in preventing reaccumulation of ascites among endomyocardial fibrosis patients in Uganda: a randomized clinical trial. BMC Res Notes. 2015;8:783. doi:10.1186/s13104-015-1761-0
   Google Scholar
• Sayegh ALC, Santos D, Marcelo R, et al. Exercise rehabilitation improves cardiac volumes and functional capacity in patients with endomyocardial fibrosis. J Cardiopulm Rehabil Prev. 2019;39:373–380. doi:10.1097/HCR.0000000000000445
   Web of Science ®Google Scholar
• Alvarez DS, Rodríguez CA, Chino-Mendoza JM, Quispe-Villca YA, Arias-Godínez JA. Endomyocardial fibrosis of the right ventricle. Imaging J Clin Medical Sci. 2019;6(1):094–096. doi:10.17352/2455-8702.000228
   Google Scholar
• Bertrand E, Chauvet J, Assamoi MO, et al. Results, indications and contra-indications of surgery in restrictive endomyocardial fibrosis: comparative study on 31 operated and 30 non-operated patients. East Afr Med J. 1985;62:151–160.
   Web of Science ®Google Scholar
• Uva MS, Jebara VA, Acar C, et al. Mitral valve repair in patients with endomyocardial fibrosis. Ann Thorac Surg. 1992;54:89–92. doi:10.1016/0003-4975(92)91146-Z
   Web of Science ®Google Scholar
• Valiathan MS, Balakrishnan KG, Sankarkumar MS, Kartha CC. Surgical treatment of endomyocardial fibrosis. Ann Thorac Med. 1987;43:68–73. doi:10.1016/S0003-4975(10)60169-5
   Google Scholar
• D’Arbela PG, Mutazindwa T, Patel AK, Somers K. Survival after the first presentation with endomyocardial fibrosis. Br Heart J. 1972;34:403–407. doi:10.1136/hrt.34.4.403
   PubMedGoogle Scholar
• Bukhman G, Ziegler J, Parry E. Endomyocardial sears. PLoS Negl Trop Dis. 2008;2(2):e97. doi:10.1371/journal.pntd.0000097
   Google Scholar
• Cools J, DeAngelo DJ, Gotlib J, et al. A tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348(13):1201–1214. doi:10.1056/NEJMoa025217
   PubMed Web of Science ®Google Scholar
• Boehme SA, Lio FM, Sikora L, et al. Cutting edge: serotonin is a chemotactic factor for eosinophils and functions additively with eotaxin. J Immunol. 2004;173(6):3599–3603. doi:10.4049/jimmunol.173.6.3599
   Web of Science ®Google Scholar
• Sliwa K, Fett J, Elkayam U. Peripartum cardiomyopathy. Lancet. 2006;368(9536):687–693. doi:10.1016/S0140-6736(06)69253-2
   Web of Science ®Google Scholar